Gefitinib, a selective EGFR tyrosine kin
✍
Hiroshi Ariyama; Baoli Qin; Eishi Baba; Risa Tanaka; Kenji Mitsugi; Mine Harada;
📂
Article
📅
2006
🏛
John Wiley and Sons
🌐
English
⚖ 355 KB
## Abstract Although gefitinib, a selective inhibitor of epidermal growth factor receptor (EGFR) tyrosine kinase, has been clinically demonstrated to be effective for certain cancer cell types, the molecular mechanisms of the anti‐tumor activity have not been fully elucidated. In this study, we inv